If you are working in any of the following scientific/business topic areas, we encourage you to submit a proposal for a podium presentation.  We are especially looking for case studies and preclinical/clinical updates with new data on the following:

  • Preclinical and clinical antibody case studies: New data and lessons learned
  • Novel antibody targets and target validation (i.e. ion channels and GPCRs)
  • Antibody lead generation: antibody display, selection and screening approaches
  • Fc modifications/post-translational modifications for specific mechanisms of action
  • “Developability” and “manufacturability” of antibodies: new technologies
  • Antibody delivery (to CNS, BBB, inside cells, tissue-specific delivery)
  • Bispecifics: tri-specifics, multispecifics, T-cell Engagers, NK engagers, non-cancer
  • ADCs (Non-cancer programs, Site-specific conjugation, preclinical tox, clinical results)
  • Immuno-oncology: Targets, NK Cells, CAR-T, TCR-T, ARMs, MDSCs, macrophages, novel checkpoints
  • Beyond classical antibodies (nanobodies, mAb fragments, DARPins, Fusions(Traps, etc.)
  • Antibodies for non-cancer indications
  • Machine learning in antibody discovery and optimization
  • Analysis of NGS antibody repertoire datasets
  • Novel technologies to accelerate antibody discovery and development

Submit a Proposal

Poster Hall Hours

Tuesday, May 10, 2016
3:00 pm - 6:30 pm

Wednesday, May 11, 2016
10:00 am - 6:30 pm

Thursday, May 12, 2016
10:30 am - 2:00 pm

Presentations should be free of commercial bias as well as any references to commercial products and services. All selected faculty are required to disclose the existence of any significant financial interest. Financial interest may affect the consideration of your presentation/proposal application.

You will be notified by the Event Review Committee if your presentation has been selected.

Call for Speakers

Deadline to Submit is 

30 August 2019


24-26 February 2020
Westin Miyako Kyoto
Kyoto, Japan

24 - 26 February 2020
Westin Miyako Kyoto
Kyoto, Japan

Antibody Engineering & Therapeutics

Terms and Conditions  |  Privacy Policy

† You may still receive emails from us regarding any current registrations or orders.